Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia

Respiratory disease is a main feature of severe COVID-19, and the potential of IL-6 receptor blockade to increase risk of pneumonia warrants vigilance and caution in its application to treat COVID-19 https://bit.ly/34Y8Ner

Detalles Bibliográficos
Autores principales: Larsson, Susanna C., Burgess, Stephen, Gill, Dipender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683792/
https://www.ncbi.nlm.nih.gov/pubmed/33214204
http://dx.doi.org/10.1183/13993003.03545-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683792/
https://www.ncbi.nlm.nih.gov/pubmed/33214204
http://dx.doi.org/10.1183/13993003.03545-2020

Ejemplares similares